You are here

Therapeutic Advances in Psychopharmacology

Therapeutic Advances in Psychopharmacology


eISSN: 20451261 | ISSN: 20451253 | Current volume: 13 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Launched in 2011
  • Gold open access journal – all articles are made freely available online immediately upon publication
  • Rigorous peer review
  • Listed in PubMed and indexed in Web of Science and Science Citation Index Expanded (SCIE)
  • Over 1 million full-text article views annually

Therapeutic Advances in Psychopharmacology (TPP) is a peer-reviewed open access journal which focuses on delivering the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. Please see the Aims and Scope for further information.

The journal is a member of the Committee on Publication Ethics (COPE).


Diversity, Equity and Inclusion Statement

Therapeutic Advances in Psychopharmacology (TPP) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the psychopharmacology community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/tpp

Please see the Submission Guidelines for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that all articles are freely accessible online in perpetuity under a Creative Commons licence.

The APC for this journal is currently 2650 USD. The article processing charge for Plain Language Summary is $4500 USD. 

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to tpp@sagepub.co.uk

Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed open access articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in psychopharmacology, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The editors welcome original research articles across all areas of psychopharmacology.

The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, health economic and pharma-economic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. The trial registry name and URL, and registration number must be included at the end of the abstract.

The journal adheres to a single-anonymised peer review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.

Editor-in-Chief
Professor David Taylor, PhD FRPharmS FRCPEdin FRCPsych(Hon) Maudsley Hospital, London, UK & King’s College London, UK
Managing Editor
Shasha Sharief SAGE Publishing, London, UK
Shikha Tomar SAGE Publishing, India
Associate Editors
Doctor Mark Horowitz, MBBS, PhD Research and Development Department at North East London NHS Trust, UK & Department of Psychiatry at University College London, UK
Professor James Rucker, MBBS MRCPsych PhD King’s College London, UK
Professor Shuichi Suetani, MB ChB, PhD Queensland Centre for Mental Health Research, Queensland, Australia
Professor Mark Taylor, MBBS; MD; FRCPE; FRCPsych; FRANZCP Griffith University School of Medicine, Queensland, Australia
Professor Ursula Werneke, MD, MSc, PgDip (LSHTM), FRCPsych Umea University, Umea, Sweden
Editorial Board
Professor Mahavir Agarwal, MBBS, MD, PhD University of Toronto, ON, Canada
Professor David Baldwin, MA, DM, FRCPsych, FRSA, FHEA University of Southampton, UK
Professor Thomas Barnes, MB BS, MD, FRCPsych, DSc Imperial College London, UK
Professor Antonio Bruno, MD, PhD Department of Biomedical, Dental Sciences and Morpho-functional Imaging (BIOMORF), University of Messina, Messina, Italy
Professor Katharina Domschke, MA, MD, PhD Universitätsklinikum Freiburg, Germany
Professor Adriana Feder, MD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Professor Paul Glue, MD, FRCPsych University of Otago, Dunedin, New Zealand
Professor Gerhard Grobler, MBChB, PhD, MMed (Psychiatry) Steve Biko Academic Hospital and University of Pretoria, South Africa
Professor Peter Haddad, MD, FRCPsych Barwon Health, Geelong, Victoria, Australia; Deakin University, Geelong, Victoria, Australia
Professor Oliver Howes, BM, BCh, MA, MRCPsych, PhD, DM King's College London, London, UK
Professor Eija Kalso, MD, DMed Sci, PhD University of Helsinki, Finland
Professor Deanna L. Kelly, PharmD, BCPP University of Maryland School of Medicine, Baltimore, MD, USA
Professor Tim Lambert, BSc MBBS PhD FRANZCP Sydney Local Health District, University of Sydney, Collaborative Centre for Cardiometabolic Health in Psychosis (ccCHiP)
Professor Anne Lingford-Hughes, PhD Imperial College London, London, UK
Professor Feng Liu, PhD Tianjin Medical University General Hospital, Tianjin, China
Professor Roger S. McIntyre, MD, FRCPC Professor of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada
Professor Jelena Milic, MSc, PhD National Institute of Public Health, University of Belgrade, Serbia
Professor Phil Mitchell, MB BS (Hons I; Syd), MD (UNSW), FRANZCP, FRCPsych University of New South Wales, NSW, Australia
Professor Antônio Egidio Nardi, PhD Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Doctor Maxine X. Patel ,MBBS, MSc, MD, FRCPsych Oxleas NHS Foundation Trust & King's College London, UK
Doctor Carol Paton, BSc, DipClinPharm, FCMHP Imperial College London, UK
Doctor Jill Rasmussen, MBChB, FRCGP, FFPM psi-napse, Dorking, UK
Professor Suzanne Reeves, PhD University College London, UK
Professor Mary Seeman, OC, MDCM, DSc University of Toronto, ON, Canada
Professor Dan Siskind, MBBS, MPH, PhD, FRANZCP The University of Queensland, St Lucia, Queensland, Australia
Professor Stephen Stahl, MD, PhD University of California, San Diego, CA, USA
Professor James Stone, MBBS, PhD, FRCPsych University of Sussex, Brighton, UK & King's College London, UK
Professor John Strang, MBBS, MD, FRCPsych, FAcMedSci King's College London, UK
Professor Rajesh Tampi, MD, MS Yale School of Medicine, New Haven, CT, USA & Creighton University School of Medicine, Omaha, NE, USA
Professor Mauricio Tohen, MD, DrPH, MBA The University of New Mexico, School of Medicine, Albuquerque, USA
Professor Michael Travis, MD University of Pittsburgh, Pittsburg, PA, USA
Professor Hiroyuki Uchida, MD, PhD Keio University Medical School, Tokyo, Japan
Professor Eduard Vieta, MD, PhD University of Barcelona, Barcelona, Spain
Professor Nicola Warren, MBBS, PhD University of Queensland, Australia
  • Clarivate Analytics: Current Contents - Clinical Medicine
  • Clarivate Analytics: Current Contents - Life Sciences
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.